Company profile for Neurotrope

NEW Drugs in Dev: 3
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders. Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes various treatment approaches for serious and difficult-to-treat diseases such as Alzheimer’s Disease, Fragile X Syndrome and Nie...
Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders. Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes various treatment approaches for serious and difficult-to-treat diseases such as Alzheimer’s Disease, Fragile X Syndrome and Niemann-Pick Type C.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1185 Avenue of the Americas, 3rd Floor New York, NY 10036
Telephone
Telephone
(973) 242-0005
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Investor pleads guilty to insider trading in Alzheimer's biotech
Investor pleads guilty to insider trading in Alzheimer's biotech

28 Jul 2022

// Nick Paul Taylor FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/investor-pleads-guilty-insider-trading-alzheimers-biotech

Nick Paul Taylor FIERCEBIOTECH
28 Jul 2022

https://www.prnewswire.com/news-releases/neurotrope-inc-completes-independent-spin-off-of-neurotrope-bioscience-inc-and-is-renamed-synaptogenix-inc-301189355.html

PRNEWSWIRE
08 Dec 2020

https://neurotrope.com/neurotrope-announces-investor-update-conference-call/

COM
02 Dec 2020

https://www.prnewswire.com/news-releases/neurotrope-and-metuchen-pharmaceuticals-announce-completion-of-merger-forming-petros-pharmaceuticals-301183662.html

PRNEWSWIRE
02 Dec 2020

https://www.prnewswire.com/news-releases/neurotrope-and-metuchen-pharmaceuticals-announce-completion-of-merger-forming-petros-pharmaceuticals-301183662.html

PRNEWSWIRE
02 Dec 2020
Neurotrope approves spin-off of Neurotrope Bioscience
Neurotrope approves spin-off of Neurotrope Bioscience

20 Nov 2020

// Akanksha Bakshi SEEKING ALPHA

https://seekingalpha.com/news/3638352-neurotrope-approves-spin-off-of-neurotrope-bioscience-announces-distribution-date

Akanksha Bakshi SEEKING ALPHA
20 Nov 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty